Financials

  • Market Capitalization 3.82 B
  • Employee 1 184
  • Founded 2015
  • CEO Christian Behrenbruch
  • Website www.telixpharma.com
  • Headquarter Australia
  • FIGI BBG01N69K900
  • Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente

Related tickers

#NamePreis24h %7d %1M %1J %MarktkapitalisierungLetzte 7 Tage
1533
IDYA
IDEAYA Biosciences, Inc. - Common Stock
40.11 USD-3.97%+1.08%+12.99%+23.11%3.87 B USD
1541
DNLI
Denali Therapeutics Inc. - Common Stock
24.00 USD-2.72%-3.54%0.00%+48.42%3.84 B USD
1557
VKTX
Viking Therapeutics, Inc. - Common Stock
32.16 USD-5.02%-4.63%-4.06%+19.24%3.75 B USD
1563
RCUS
Arcus Biosciences, Inc. Common Stock
29.19 USD-4.61%-4.30%+6.46%+176.42%3.72 B USD